Loracarbef

氯碳头孢

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameLoracarbef
Drug Alias Nameloracarbefum氯拉卡比洛拉卡比劳拉卡比拉碳头孢 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1991/12/31
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKing Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeJ01DC08
Related LinksWikipediaDrugBankKEGG